Oscar Health Inc

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

OSCR$33.47+4.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders' Equity

	Three Months Ended September 30,		Nine Months Ended September 30,
(in thousands)	2024	2023	2024	2023
Common stock, Class A shares
Balance, beginning of period	206,153	186,790	193,875	181,176
Issuance of common stock from equity incentive plans	5,549	4,006	17,827	9,619
Balance, end of period	211,702	190,796	211,702	190,796
Common stock, Class B shares
Balance, beginning of period	35,514	35,116	35,514	35,116
Issuance of common stock from equity incentive plans	—	180	—	180
Balance, end of period	35,514	35,296	35,514	35,296
Common stock, Class A
Balance, beginning of period	$2	$2	$2	$2
Balance, end of period	2	2	2	2
Treasury stock
Balance, beginning of period	(2,923)	(2,923)	(2,923)	(2,923)
Balance, end of period	(2,923)	(2,923)	(2,923)	(2,923)
Additional paid-in capital
Balance, beginning of period	3,786,885	3,620,766	3,682,294	3,509,007
Issuance of common stock from equity incentive plans	18,560	300	64,571	2,886
Stock-based compensation expense	31,924	30,449	90,504	139,151
Joint venture contribution	—	2,020	—	2,491
Balance, end of period	3,837,369	3,653,535	3,837,369	3,653,535
Accumulated Deficit
Balance, beginning of period	(2,643,140)	(2,661,287)	(2,876,715)	(2,605,987)
Net income (loss)	(54,596)	(65,398)	178,979	(120,698)
Balance, end of period	(2,697,736)	(2,726,685)	(2,697,736)	(2,726,685)
Accumulated other comprehensive income (loss)
Balance, beginning of period	(2,625)	(6,856)	1,309	(9,715)
Unrealized gains on investments, net	28,676	2,403	24,742	5,262
Balance, end of period	26,051	(4,453)	26,051	(4,453)
Noncontrolling interests
Balance, beginning of period	2,369	2,263	2,150	2,016
Net income (loss) attributable to noncontrolling interests	208	(305)	427	(58)
Balance, end of period	2,577	1,958	2,577	1,958
Total stockholders' equity	$1,165,340	$921,434	$1,165,340	$921,434

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.